Viewing nowCombinationDistab 40/5mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Samnam Pharmaceutical Co., Ltd.

MFDS item code 201605767 · Approved 2016.09.30 · Insurance code 653702220
Treatment of essential hypertension not controlled with monotherapy
This medicine is used in patients with essential hypertension who do not achieve adequate blood pressure control with telmisartan or amlodipine monotherapy. It helps lower and control blood pressure effectively in such cases. Hence, this medicine can be used for the stable management of blood pressure in essential hypertension therapy.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that the tablet be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, as follows, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring careful administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medicine should not be used during pregnancy, especially in the second and third trimesters, as it may pose serious risks to the fetus. It should not be administered to women who are allergic to the active ingredients, those who are pregnant or breastfeeding, patients with obstructive biliary disease, severe hepatic impairment, or certain heart conditions. Caution should be exercised in patients with primary aldosteronism, impaired liver function, gastrointestinal diseases, renal artery hypertension, elderly patients, and others. Common side effects such as dizziness and peripheral edema may occur when taking this medicine, and serious side effects like fainting or heart-related issues may rarely occur. Avoid the use of this medicine during pregnancy, and if pregnancy is confirmed, stop taking it immediately and switch to another safe medication. Due to the risk of hypotension, patients with insufficient fluids or salt should correct their condition or adjust the dose under medical supervision before taking this medicine. This medicine may increase serum potassium levels, and regular testing of potassium levels and kidney function is necessary. Patients with heart failure or cardiovascular diseases need careful management when taking this medicine, especially those with severe heart failure. This medicine contains sorbitol and is not suitable for patients with fructose intolerance. Diabetic patients should consult with their physician as the risk of coronary artery disease may increase. Dizziness or drowsiness may occur while taking this medication, so caution is needed when driving or operating hazardous machinery. There may be interactions with other antihypertensive medications, so inform your doctor or pharmacist if you are taking other medications. Overdose may result in hypotension, arrhythmia, renal failure, and immediate medical attention is required. This medicine is not recommended for children and adolescents under 18 due to insufficient evidence of safety and efficacy. Elderly patients may be more sensitive to this medicine, so it is advisable to start with a lower dose and gradually increase it. This medicine should be kept out of reach of children and stored in a cool, dry place in the prescribed container.
Not everyone experiences these, and they can vary from person to person.
This medicine is sensitive to light, so it should be stored in a container that does not allow light to pass through. Additionally, it is recommended to store the medicine at room temperature, between 1 to 30 degrees Celsius, to ensure safe storage.
White and light blue, bilaterally convex oval dual tablet
30 tablets (10 tablets/PTP*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Samnam Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.